Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer.
about
Advancing cancer drug discovery towards more agile development of targeted combination therapies.Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptomsBevacizumab in the treatment of five patients with breast cancer and brain metastases: Japan Breast Cancer Research Network-07 trial.Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel.Bevacizumab combination therapy: for the first-line treatment of advanced epithelial ovarian, fallopian tube or primary peritoneal cancer.Bevacizumab combination therapy: a review of its use in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).Cilostazol improves hippocampus-dependent long-term memory in mice.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Q34100574-52CD1B54-0A9A-48C6-8D9C-AEDFECC50A0DQ35049356-874BF602-C822-4BA5-8A72-80D0320B48E1Q36284456-93E3612E-F4C3-4BE7-83BE-3092A4411CD1Q37133208-A34D3AF3-38C6-4247-AA9C-1DA5AD97C052Q38003707-9447272E-8FAA-4998-A15C-2CB66A2B1AEAQ38111265-C3A1F9C3-64B6-4DEB-9B91-934836CAAF3CQ38827793-E774D9F9-921D-432E-A990-CC99F73A241AQ47925672-10B63F9B-9AE3-43AE-95FA-24C4F3FF79CDQ57105258-6CF4601F-2E9A-4541-BB1C-08F5A66F729F
P2860
Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@en
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@nl
type
label
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@en
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@nl
prefLabel
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@en
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@nl
P2860
P1433
P1476
Bevacizumab: a review of its u ...... tive metastatic breast cancer.
@en
P2093
Katherine F Croom
Sohita Dhillon
P2860
P304
P356
10.2165/11207720-000000000-00000
P577
2011-11-01T00:00:00Z
P6179
1019586289